Royalty Pharma holds investor calls for dollar-denominated multiple-tranche note offering

By Cristal Cody

Tupelo, Miss., Aug. 19 – Royalty Pharma plc held fixed income investor calls on Wednesday for a Rule 144A and Regulation S dollar-denominated offering of senior notes (Baa3/BBB-/BBB-) in multiple tranches, according to a market source and a press release.

BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC are the bookrunners.

The notes are guaranteed by Royalty Pharma Holdings Ltd.

Proceeds will be used to repay the company’s term loan A and term loan B facilities and for general corporate purposes.

Royalty Pharma is a New York-based acquirer of royalty interests in marketed and late-stage biopharmaceutical products.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.